tetano
Editor, Senior Moderator
Cureus
. 2024 Jan 5;16(1):e51682.
doi: 10.7759/cureus.51682. eCollection 2024 Jan. Bilateral Sequential Abducens Nerve Palsy After Pfizer-BioNTech COVID-19 Vaccine (BNT162b2): A Case Report and Literature Review
Malak F Albattah[SUP] 1 [/SUP], Kefah Al-Hayk[SUP] 1 [/SUP], Mutasim Albattah[SUP] 2 [/SUP], Mohammad A Alshrouf[SUP] 3 [/SUP]
Affiliations
This case report details the occurrence of bilateral sequential abducens nerve palsy in a previously healthy 42-year-old woman two days after receiving her first dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2). Despite the widespread global administration of COVID-19 vaccines, instances of abducens palsy following vaccination are limited in the available literature. Considering the temporal association between vaccination and symptom onset, the absence of underlying medical conditions predisposing to such neurological manifestations, normal brain imaging results, the occurrence of other cranial palsies post-vaccination, and analogous occurrences after different vaccinations, we propose a plausible connection between the patient's abducens palsy and the COVID-19 vaccination. Our findings contribute to the growing body of evidence regarding the side effects and safety profile of COVID-19 vaccines. Importantly, the resolution of symptoms with conservative management and the uneventful administration of the second vaccine dose suggest that the observed abducens palsy may be a transient and isolated reaction.
Keywords: abducens nerve palsy; coronavirus; covid-19; ophthalmoplegia; sixth nerve palsy; vaccination.
. 2024 Jan 5;16(1):e51682.
doi: 10.7759/cureus.51682. eCollection 2024 Jan. Bilateral Sequential Abducens Nerve Palsy After Pfizer-BioNTech COVID-19 Vaccine (BNT162b2): A Case Report and Literature Review
Malak F Albattah[SUP] 1 [/SUP], Kefah Al-Hayk[SUP] 1 [/SUP], Mutasim Albattah[SUP] 2 [/SUP], Mohammad A Alshrouf[SUP] 3 [/SUP]
Affiliations
- PMID: 38313970
- PMCID: PMC10838386
- DOI: 10.7759/cureus.51682
This case report details the occurrence of bilateral sequential abducens nerve palsy in a previously healthy 42-year-old woman two days after receiving her first dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2). Despite the widespread global administration of COVID-19 vaccines, instances of abducens palsy following vaccination are limited in the available literature. Considering the temporal association between vaccination and symptom onset, the absence of underlying medical conditions predisposing to such neurological manifestations, normal brain imaging results, the occurrence of other cranial palsies post-vaccination, and analogous occurrences after different vaccinations, we propose a plausible connection between the patient's abducens palsy and the COVID-19 vaccination. Our findings contribute to the growing body of evidence regarding the side effects and safety profile of COVID-19 vaccines. Importantly, the resolution of symptoms with conservative management and the uneventful administration of the second vaccine dose suggest that the observed abducens palsy may be a transient and isolated reaction.
Keywords: abducens nerve palsy; coronavirus; covid-19; ophthalmoplegia; sixth nerve palsy; vaccination.